NYSEARCA:BBP Virtus LifeSci Biotech Products ETF (BBP) Price, Holdings, & News $69.29 +0.32 (+0.46%) As of 03:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BBP alerts:Sign Up Key Stats Today's Range$69.58▼$69.6050-Day Range$61.00▼$70.3652-Week Range$48.65▼$70.61Volume582 shsAverage Volume2,618 shsMarket Capitalization$27.72 millionAssets Under Management$27.62 millionDividend YieldN/ANet Expense Ratio0.79%Aggregate RatingModerate Buy ETF Overview The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus. Read More Virtus LifeSci Biotech Products ETF ExpensesTypeBBPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.79%0.56%0.56%0.51%0.53%Other Expenses0.00%0.47%0.56%0.59%0.56%Total Expense0.79%0.75%0.76%0.74%0.73%Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%Net Expense0.79%0.60%0.63%0.58%0.60% Receive BBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Products ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BBP ETF News HeadlinesVirtus LifeSci Biotech Clinical Trials ETF declares annual distribution of $0.2394December 23, 2024 | msn.comCanadian ETF Comparison Series: FCUQ vs. ZUQ.FDecember 17, 2024 | theglobeandmail.com3 Little Known AI Stocks With 10X PotentialEveryone's buying Nvidia. The financial media can't stop talking about it. Your neighbor probably owns it. That's exactly why I'm looking elsewhere. See, when everyone piles into the same trade, the easy money is already gone. The real profits come from finding what the crowd is missing.September 17 at 2:00 AM | TradingTips (Ad)BBP Virtus LifeSci Biotech Products ETFOctober 9, 2024 | seekingalpha.comVirtus LifeSci Biotech Products ETF (BBP)August 25, 2024 | investing.comVirtus LifeSci Biotech Clinical Trials ETF (BBC)August 16, 2024 | investing.comSee More Headlines BBP ETF - Frequently Asked Questions How have BBP shares performed this year? Virtus LifeSci Biotech Products ETF's stock was trading at $60.02 at the start of the year. Since then, BBP shares have increased by 16.0% and is now trading at $69.5960. Who are Virtus LifeSci Biotech Products ETF's major shareholders? Top institutional investors of Virtus LifeSci Biotech Products ETF include Flow Traders U.S. LLC (1.85%). How do I buy shares of Virtus LifeSci Biotech Products ETF? Shares of BBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Virtus LifeSci Biotech Products ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Virtus LifeSci Biotech Products ETF investors own include Inovio Pharmaceuticals (INO), Micron Technology (MU), Sanofi (SNY), Gilead Sciences (GILD), Simon Property Group (SPG), Intel (INTC) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Fund Details IssuerVirtus Fund NameVirtus LifeSci Biotech Products ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BBP Inception Date12/16/2014 Fund ManagerMatthew B. Brown, Seth Kadushin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkLifeSci Biotechnology Products Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings59 Fund Statistics Assets Under Management$27.62 million Average Daily Volume$2.31 thousand Discount/Premium-0.07% Administrator, Advisor and Custodian AdministratorVirtus ETF Solutions, LLC AdvisorVirtus ETF Advisers, LLC CustodianThe Bank of New York Mellon Corporation DistributorETF Distributors LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume6 Put Options6 Call Options12 Short Interest3,200 shs Miscellaneous Outstanding Shares400,000Beta0.73 Creation Unit50,000 Creation Fee$500.00 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report Top 10 BBP HoldingsArdelyx (NASDAQ:ARDX)Holding Weight: 2.83%Ionis Pharmaceuticals (NASDAQ:IONS)Holding Weight: 2.83%Travere Therapeutics (NASDAQ:TVTX)Holding Weight: 2.64%Aurinia Pharmaceuticals (NASDAQ:AUPH)Holding Weight: 2.45%Rhythm Pharmaceuticals (NASDAQ:RYTM)Holding Weight: 2.45%Mirum Pharmaceuticals (NASDAQ:MIRM)Holding Weight: 2.44%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 2.42%Insmed (NASDAQ:INSM)Holding Weight: 2.37%Madrigal Pharmaceuticals (NASDAQ:MDGL)Holding Weight: 2.33%Ligand Pharmaceuticals (NASDAQ:LGND)Holding Weight: 2.30%Full Holdings DetailsBBP Sector ExposureBBP Industry Exposure This page (NYSEARCA:BBP) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
